(Date:11/20/2008)..., Nov. 20 Clinical data from a pro... Annual Veith Symposium shows DVT,treatment with ...chus,Vascular, Inc. (Santa Clara, CA) successfull...out 20 minutes. , This technique, called is...blood flow more quickly and safely than current ca...
(Date:11/19/2008)..., Study did not achieve statistical significance...stCall/ -- Pharmos Corporation (Nasdaq: PARS ) t...trial of its topical NanoEmulsion (NE) drug delive...nolamine. , , The multi-center, randomized,...d the safety and efficacy of the Company,s 3% Dicl...
(Date:11/18/2008)...November 19 NeuroDiscove...ce provider and drug development Company,and Sos...4565), a leading,international biopharmaceutical ...esenting further pivotal pre-clinical efficacy dat... a potential therapy for neuropathic pain and has,...
(Date:11/18/2008)...ed study will enroll newly diagnosed, elderly AML ...wswire/ -- Celator Pharmaceuticals today announced...omized Phase 2 clinical study of CPX-351 (Cytarabi...th newly diagnosed acute myeloid leukemia (AML). ,...eldman, MD at the Weill Medical College of Cornel...
Breaking Medicine Technology:Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 3Quigley Anti Viral Compound QR448 28a 29 Successfully Prevents Transmission of Infectious Bronchitis in Chickens 3068 1Quigley Anti Viral Compound QR448 28a 29 Successfully Prevents Transmission of Infectious Bronchitis in Chickens 3068 2Quigley Anti Viral Compound QR448 28a 29 Successfully Prevents Transmission of Infectious Bronchitis in Chickens 3068 3Quigley Anti Viral Compound QR448 28a 29 Successfully Prevents Transmission of Infectious Bronchitis in Chickens 3068 4ProSource 2 0 Offers Value Savings for Lab Supplies 7714 1ProSource 2 0 Offers Value Savings for Lab Supplies 7714 2Why some primates but not humans can live with immunodeficiency viruses and not progress to AIDS 4907 1Why some primates but not humans can live with immunodeficiency viruses and not progress to AIDS 4907 2Why some primates but not humans can live with immunodeficiency viruses and not progress to AIDS 4907 3Why some primates but not humans can live with immunodeficiency viruses and not progress to AIDS 4907 4Sir David Lane honored with Royal Gold Medal by Royal Society of Edinburgh 4902 1...BUSINESS WIRE)--Jun 6, 2007 - Metabasis Therapeuti...y focused on the,discovery, development and commer...tabolic and liver diseases by applying unique,capa...s, announced,today that two posters were presented... Toronto, Canada., Both posters provide data on MB...
...ng ROX-888 Required Significantly Less Morphine Af...le NDA In 2008, MENLO PARK, CA (June 6, 2007) &nda... novel intranasal,analgesic, rapidly and effective...ho had undergone major abdominal surgery in,a Phas...and final Phase 3 clinical study," said,ROXRO PHAR...
Other Medicine Technology:Metabasis Therapeutics Presents Results of Preclinical Studies for,MB07811, Its Novel Product Candidate for the Treatment of,Hyperlipidemia, at the Endocrine Society's Annual Meeting 2Metabasis Therapeutics Presents Results of Preclinical Studies for,MB07811, Its Novel Product Candidate for the Treatment of,Hyperlipidemia, at the Endocrine Society's Annual Meeting 3Metabasis Therapeutics Presents Results of Preclinical Studies for,MB07811, Its Novel Product Candidate for the Treatment of,Hyperlipidemia, at the Endocrine Society's Annual Meeting 4Roxro Pharma’s Novel Intranasal Pain Reliever Effective, Well,Tolerated in Phase 3 Study 2(Date:11/21/2008)...ning increases production of neural stem cells , ...experiments in mice, exercise appears to reverse t...sually seen with aging, Taiwanese researchers repo...s ability to stave off aging appears to be due to ... is essential for the production of new brain cell...
(Date:11/21/2008)...re/ -- For the second year in a row and the thir... Worldwide,s agency network won more creative awar...l international RX Club Show. , , Nine McC...l of 59 RX Club Awards of Excellence, including a ... Worldwide agencies include Caudex Medical, echo T...
(Date:11/21/2008)... -- Innerscope Research(TM), a revolutionary,biom...l Response Measurement,announced today the appoi...,company,s research and development, business str...ee appointments, who deliver a combined 60 years o...ncial Officer and Vice President of,Strategy; Dr....
(Date:11/21/2008)...(Nov. 21, 2008) How can moss help us to treat Al...stem tell us about evolution? Can genetic studies...nserve rare species? What can quail teach us abou...es? Will studies of choanoflagellates unravel the... questions in biology, scientists are increasing t...
Breaking Medicine News(10 mins):Health News:Exercise Keeps the Brain Young 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 3Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 4Health News:Innerscope Research Strengthens Management Team With Three Executive Appointments 2Health News:A new world of research possibilities with 'Emerging Model Organisms' 2Cushing bayonet.
Angulated, blunt and pointed tips.
Straight, blunt tips.
Pointed, 12 cm long.
Medicine Products: